Quote on Alembic Pharmaceuticals By Mr. Yash Gupta, Angel One Ltd
![](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2022/01/b91932631daf60dfa057091b18351e42.jpg)
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Below is quote on Alembic Pharmaceuticals receives USFDA Tentative Approval for Dronedarone, positive news for alembic pharmaceuticals, stock up 2% by Mr. Yash Gupta, Equity Research Analyst, Angel One Ltd
Alembic Pharmaceuticals announced that the company has received US Food & Drug Administration (USFDA) Tentative Approval for Dronedarone Tablets USP, 400 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product of Multaq Tablets, 400 mg, of Sanofi-Aventis. Dronedarone is indicated to reduce the risk of hospitalization for atrial fibrillation in patients in sinus rhythm with a history of paroxysmal or persistent atrial fibrillation. Dronedarone Tablets USP, 400 mg have an estimated market size of US$ 500 million for twelve months ending September 2021 according to IQVIA. This is a big approval for Alembic Pharmaceuticals, currently the company is trading at EV/EBITDA of 13.4 times and PE of 18.08 which is in range of the last 5 year. We have a neutral call on Alembic Pharmaceuticals Limited.
Above views are of the author and not of the website kindly read disclaimer
![](https://portfolio.investmentguruindia.com/uploads/news/Skills Revolution1231.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/cummins.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/investment37.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Tata Steel Ltd.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Tarun Chugh, MD & CEO, Bajaj Allianz Life.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/car37.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/jitin37.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/sunteck realty.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Rupee 25.jpg)
Tag News
![](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2023/05/892c2d00d68c33104f9bb896e2cd4a96.jpg)
India's MedPlus Health posts two-fold surge in Q4 profit on strong sales
![Alembic Pharmaceuticals surges on getting EIR for Solid Oral Formulation Facility at Vadodara](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2023/05/22be0ecb7dfcd46b119b708cd51da380.jpg)
![Alembic Pharmaceuticals gains on completing ANVISA GMP audit at API-III Facility without any observations](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2023/03/ac1cda4099cf0c445fd6d2081f02ab14.jpg)
![Alembic Pharmaceuticals trades higher on completing USFDA`s inspection at Derma Facility without any observations](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2023/03/6a3f74c50ac1ab127e5882adbac0bbb8.jpg)